key: cord-1032805-1qhtdwpm
authors: Miyashita, Naoyuki; Nakamori, Yasushi; Ogata, Makoto; Fukuda, Naoki; Yamura, Akihisa; Ishiura, Yoshihisa; Nomura, Shosaku
title: Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines
date: 2021-11-09
journal: Respirology
DOI: 10.1111/resp.14173
sha: 3d32f5fa59f757fa877da86c3d96d51286a373b6
doc_id: 1032805
cord_uid: 1qhtdwpm

nan

The coronavirus disease 2019 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a sudden and substantial increase in hospitalizations for pneumonia worldwide. 1 Although the reverse transcription PCR assay is a commonly used tool for the diagnosis of COVID-19, the sensitivity of PCR is not high using oropharyngeal and nasopharyngeal swab specimens and depends on the time of collection and the collector. 2, 3 The Japanese Respiratory Society (JRS) scoring system, consisting of six parameters, is a useful tool for the early presumptive diagnosis of mild-to-moderate atypical pneumonia, mainly Mycoplasma pneumoniae pneumonia. 4 These parameters were: (1) age < 60 years, (2) no or minor comorbid illness, (3) presence of stubborn cough, (4) absence of chest adventitious sounds, (5) no sputum or no identified aetiological agent by rapid diagnostic tests (Gram staining, urinary antigen tests and nasopharyngeal antigen test) and (6) a peripheral white blood cell (WBC) count of <10,000/μl. We evaluated whether the JRS scoring system could be adapted to the diagnosis of mild-to-moderate SARS-CoV-2 pneumonia.

This study was conducted at five institutions between February 2020 and June 2021, and assessed a total of 823 patients with SARS-CoV-2 pneumonia (335 had lineage B.1.1.7., also known as the Alpha variant; nasopharyngeal swab specimens according to the protocol recommended by the National Institute of Infectious Diseases, Japan. Matching rates to the six parameters of the JRS scoring system were identical in both non-Alpha variant and Alpha variant groups, and high matching rates were observed in the following parameters: absence of chest adventitious sounds, 71.6% (non-Alpha variant group, 73.2%; Alpha variant group, 69.3%); no sputum or no identified aetiological agent by rapid diagnostic tests, 87.1% (90.0% and 83.0%); and a peripheral WBC count of <10,000/μl, 97.6% (98.2% and 96.7%). The matching rates of the other three parameters were as follows: age < 60 years, 42.2% (43.0% and 40.9%); no or minor comorbid illness, 57.8% (57.8% and 57.9%); and presence of stubborn cough, 10.4% (9.4% and 11.9%). The sensitivity and specificity for the diagnosis of atypical pneumonia in patients with SARS-CoV-2 pneumonia based on four or more parameters were 58.3% (58.8% in the non-Alpha variant group and 57.6% in the Alpha variant group, respectively) and 92.2%, respectively.

When the diagnostic sensitivity was analysed for different ages stratified into the 10-year groups, the diagnostic sensitivity of patients in both the non-Alpha variant and Alpha variant groups was highest in the 20-39-year age group and decreased in order from the youngest to the oldest age group (Table 1) . There was a clear difference between elderly (aged ≥60 years) and non-elderly (aged <60 years) patients with SARS-CoV-2 pneumonia. The diagnostic sensitivity for SARS-CoV-2 pneumonia was 95.5% for non-elderly patients and 32.5% for elderly patients.

Our results demonstrated that the JRS scoring system is a useful tool for distinguishing between SARS-CoV-2 pneumonia and bacterial pneumonia in patients aged <60 years, but not in patients aged ≥60 years. The severity of pneumonia was evaluated using predictive rules via the A-DROP system (a 5-point scoring system) proposed by the JRS guidelines: age over 70 years in men and over 75 years in women, dehydration, respiratory failure, orientation disturbance and low blood pressure. An A-DROP score of 0-3 points was classified as mild-to-moderate pneumonia.

Supervision: Naoyuki Miyashita (lead), Yasushi Nakamori (equal), Yoshihisa Ishiura (supporting)

A novel coronavirus from patients with pneumonia in China

Detection of SARS-CoV-2 in different types of clinical specimens

Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure

Committee for the Japanese Respiratory Society Guidelines for the Management of Respiratory Infections. Guidelines for the management of community acquired pneumonia in adults

Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines

The study protocol was approved by the Ethics Committee of Kansai Medical University and all participating facilities (approval number 2020319). Informed consent was obtained from all individual participants in the study.